For example, a recent survey of British EDs demonstrated that medications required to treat bradykinin-mediated angioedema were available in the majority of hospitals with specialist immunology services, but were not readily accessible in the ED (e.g., located in the main pharmacy). The gene discussed is KNG1; the disease is angioedema.